Vectura Group PLC (VEC) Insider Andrew Derodra Buys 153 Shares

Vectura Group PLC (LON:VEC) insider Andrew Derodra acquired 153 shares of Vectura Group stock in a transaction on Friday, December 8th. The shares were bought at an average price of GBX 98 ($1.32) per share, with a total value of £149.94 ($201.80).

Andrew Derodra also recently made the following trade(s):

  • On Wednesday, November 8th, Andrew Derodra acquired 156 shares of Vectura Group stock. The shares were bought at an average price of GBX 96 ($1.29) per share, with a total value of £149.76 ($201.56).
  • On Friday, October 6th, Andrew Derodra bought 142 shares of Vectura Group stock. The stock was acquired at an average price of GBX 106 ($1.43) per share, with a total value of £150.52 ($202.58).

Vectura Group PLC (VEC) opened at GBX 100.80 ($1.36) on Tuesday. Vectura Group PLC has a 12 month low of GBX 86.50 ($1.16) and a 12 month high of GBX 166.97 ($2.25).

A number of equities research analysts have recently commented on the stock. J P Morgan Chase & Co reiterated an “overweight” rating on shares of Vectura Group in a research report on Thursday, November 16th. Peel Hunt reiterated a “hold” rating and issued a GBX 160 ($2.15) target price on shares of Vectura Group in a research report on Wednesday, November 15th. Panmure Gordon reiterated a “buy” rating and issued a GBX 150 ($2.02) target price on shares of Vectura Group in a research report on Thursday, November 9th. Numis Securities reduced their target price on shares of Vectura Group from GBX 205 ($2.76) to GBX 170 ($2.29) and set a “buy” rating for the company in a research report on Thursday, November 9th. Finally, Shore Capital reiterated a “buy” rating on shares of Vectura Group in a research report on Thursday, November 9th. One analyst has rated the stock with a sell rating, two have issued a hold rating and seven have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of GBX 185.25 ($2.49).

ILLEGAL ACTIVITY NOTICE: “Vectura Group PLC (VEC) Insider Andrew Derodra Buys 153 Shares” was published by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another site, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/12/12/vectura-group-plc-vec-insider-andrew-derodra-buys-153-shares.html.

About Vectura Group

Vectura Group plc is engaged in research, development and commercialization of therapeutic products and drug delivery systems for human use. The Company’s products include Ultibro Breezhaler (European Union (EU) and Rest of World (RoW)) – LABA-LAMA; Seebri Breezhaler (EU and RoW) – LAMA; AirFluSal Forspiro (EU and RoW) – ICS-LABA; ADVATE (Global) – Antihaemophilic Factor (Recombinant); Adept (Global) – Icodextrin; Anoro Ellipta (Global) – LAMA-LABA; Relvar Ellipta/Breo Ellipta (Global) – ICS-LABA, and Incruse Ellipta (Global) – LAMA.

Insider Buying and Selling by Quarter for Vectura Group (LON:VEC)

Receive News & Ratings for Vectura Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vectura Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply